|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM188824529 |
003 |
DE-627 |
005 |
20231223182605.0 |
007 |
cr uuu---uuuuu |
008 |
231223s2009 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2009.05.002
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0629.xml
|
035 |
|
|
|a (DE-627)NLM188824529
|
035 |
|
|
|a (NLM)19473882
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Cummings, Kara L
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection
|
264 |
|
1 |
|c 2009
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 01.09.2009
|
500 |
|
|
|a Date Revised 20.10.2021
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a CD4+ T cell responses are impaired in chronic HCV infection. To determine factor(s) involved in CD4+ T cell dysregulation, we examined the effect of extracellular core on the alteration of CD4+ T cell responses and the cell surface level of core-binding protein, gC1qR on CD4+ T cells from acute HCV patients with resolved and chronic infection. During the acute phase of infection, the frequency of gC1qR+CD4+ T cells increased in both resolved and chronic HCV infection compared to healthy controls. Notably, 6 months later, the frequency of gC1qR+CD4+ T cells maintained elevated in chronic patients compared to that in resolved patients. In addition, TCR stimulation increased the frequency of gC1qR+CD4+ T cells, resulting in core-induced inhibition of T cell responses in both resolved and chronic patients. These results suggest that HCV infection expands gC1qR+CD4+ T cells, which increase the susceptibility to core-mediated immune dysregulation and facilitate the establishment of HCV persistency
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
650 |
|
7 |
|a C1QBP protein, human
|2 NLM
|
650 |
|
7 |
|a Carrier Proteins
|2 NLM
|
650 |
|
7 |
|a Hepatitis C Antigens
|2 NLM
|
650 |
|
7 |
|a Mitochondrial Proteins
|2 NLM
|
650 |
|
7 |
|a Receptors, Antigen, T-Cell
|2 NLM
|
650 |
|
7 |
|a Viral Core Proteins
|2 NLM
|
650 |
|
7 |
|a core protein p22, Hepatitis C virus
|2 NLM
|
700 |
1 |
|
|a Rosen, Hugo R
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hahn, Young S
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 132(2009), 3 vom: 01. Sept., Seite 401-11
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:132
|g year:2009
|g number:3
|g day:01
|g month:09
|g pages:401-11
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2009.05.002
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 132
|j 2009
|e 3
|b 01
|c 09
|h 401-11
|